Sodium chloride, 0.9% 10 ml 10 pcs

Pharmacotherapeutic group: Rehydrating agent

ATC:

.

Indications

Plasma-isotonic fluid replacement, hypochloremic alkalosis, hyponatremia with dehydration, intoxication, dissolution and dilution of parenterally administered drugs (as a base solution).

Pharmacological effect

Pharmacotherapeutic group: Rehydrating agent

ATX:

B.05.C.B.01 Sodium chloride

B.05.X.A.03 Sodium chloride

Pharmacodynamics:

Plasma replacement agent. Has a detoxifying and rehydrating effect. Replenishes sodium deficiency in various pathological conditions of the body.

A 0.9% sodium chloride solution is isotonic to human plasma, therefore it is quickly removed from the vascular bed, only temporarily increasing the volume of circulating blood (effectiveness for blood loss and shock is insufficient).

Pharmacokinetics:

The concentration of sodium ions is 142 mmol/l (plasma) and 145 mmol/l (interstitial fluid), the concentration of chloride is 101 mmol/l (interstitial fluid). Excreted by the kidneys.

Special instructions

When carrying out any infusion, it is necessary to monitor the patient’s condition, clinical and biological indicators, it is especially important to evaluate blood plasma electrolytes.

In children, sodium excretion may slow down due to immature kidney function. Therefore, in such patients, repeated infusions should be carried out only after determining the concentration of sodium in the blood plasma.

Hypersensitivity reactions

There is evidence of the development of hypersensitivity reactions or infusion reactions during the use of the drug, including hypotension, pyrexia, tremor, chills, urticaria, rash and itching. If hypersensitivity reactions or infusion reactions occur, the infusion should be stopped immediately and the necessary therapeutic measures taken as indicated.

Risk of hypervolemia and/or solute overload and electrolyte imbalances

Depending on the volume and speed of infusion, the following conditions may develop during intravenous administration of the drug:

hypervolemia and/or solute overload, leading to overhydration and, for example, congestion, including central and peripheral edema;
clinically significant disturbances in electrolyte and acid-base balance.

Use in patients with renal failure

In patients with renal failure, the drug should be used with extreme caution or not used at all. Use of the drug in such patients may lead to sodium retention.

Use only a clear solution, without visible inclusions and if the packaging is not damaged.

Administer immediately after connecting to the infusion system. The solution should be administered using sterile equipment in compliance with the rules of asepsis and antisepsis. To prevent air from entering the infusion system, it should be filled with solution, releasing any remaining air from the container completely.

As with all parenteral solutions, the compatibility of added substances with the solution must be determined before reconstitution. Drugs known to be incompatible with it should not be used with sodium chloride solution 0.9%. A physician should determine the compatibility of added medicinal substances with a 0.9% sodium chloride solution by checking for possible discoloration and/or the appearance of sediment, insoluble complexes or crystals. Before addition, it is necessary to determine whether the substance being added is soluble and stable in water at the pH level of a 0.9% sodium chloride solution. When adding a drug, it is necessary to determine the isotonicity of the resulting solution before administration.

Before adding drugs to the solution, they must be thoroughly mixed in compliance with aseptic rules. The prepared solution should be administered immediately after preparation, do not store! Do not freeze! Any unused dose should be discarded. Adding other drugs or changing the administration technique may cause fever due to the possible entry of pyrogens into the body. If undesirable reactions develop, you must immediately stop administering the solution.

The Polyflak bottle allows you to dilute dry medications and transfer liquid dosage forms into the bottle using a double-sided cannula for mixing medications.

Freezing during transportation is allowed.

After transportation at subzero temperatures, the drug must be kept at room temperature until completely defrosted.

Freezing the drug, provided the bottle is sealed, is not a contraindication to its use.

Impact on the ability to drive vehicles. Wed and fur.:

Clinical studies to evaluate the effect of the drug on the ability to drive vehicles and machines have not been conducted.

Active ingredient

Sodium chloride

Composition

1 liter of solution contains:

active ingredient:

sodium chloride – 9.0 g;

excipient:

water for injection – up to 1.0 l.

Theoretical osmolarity 308 mOsm/l.

Pregnancy

The solution can be administered during pregnancy and lactation. There is insufficient data on the use of the drug during pregnancy and breastfeeding.

It can be used during pregnancy and breastfeeding in cases where the expected benefit to the mother outweighs the possible risk of complications.

Contraindications

Hypernatremia, hyperchloremia, hypokalemia; extracellular hyperhydration; intracellular dehydration; circulatory disorders associated with the risk of developing cerebral and pulmonary edema; cerebral edema; pulmonary edema; decompensated heart failure; chronic renal failure; conditions that can cause sodium retention, hypervolemia and edema (central and peripheral), such as: primary aldosteronism and secondary aldosteronism due to, for example, arterial hypertension, congestive heart failure, liver disease (including cirrhosis), kidney disease (including renal artery stenosis and nephrosclerosis), preeclampsia; concomitant administration of glucocorticosteroids in large doses; contraindications to drugs added to the solution.

With caution:

Chronic heart failure, chronic renal failure (oligo-, anuria), acidosis, arterial hypertension, peripheral edema, toxicosis of pregnancy.

Side Effects

If the drug is used correctly, adverse reactions are unlikely.

Adverse reactions are listed below in descending order of their severity, without indicating the frequency of occurrence.

From the circulatory system: acidosis, overhydration, hypokalemia.

From the immune system: hypersensitivity reactions or infusion reactions, including hypotension, pyrexia, tremor, chills, urticaria, rash, itching.

General and administration site disorders: administration site reactions such as injection site erythema, injection site hemorrhage/hematoma, burning sensation, injection site urticaria, injection site thrombosis or phlebitis.

Other: fever, infection at the injection site (if antiseptic rules are violated).

When using the drug as a base solution (solvent) for other drugs, the likelihood of side effects is determined by the properties of these drugs. In this case, if adverse reactions occur, the administration of the solution should be suspended, the patient’s condition assessed, adequate measures taken, and the remaining solution retained for analysis, if necessary.

Interaction

Compatible with colloid hemodynamic blood substitutes (mutually enhancing effect).

When mixing with other drugs, visual control for compatibility is necessary (chemical or therapeutic incompatibility may occur).

Overdose

Symptoms: nausea, vomiting, diarrhea, cramping abdominal pain, thirst, decreased salivation and lacrimation, increased sweating, fever, tachycardia, increased blood pressure, renal failure, peripheral edema, pulmonary edema, respiratory arrest, headache, dizziness, anxiety, irritability, weakness, muscle cramps and rigidity, generalized convulsions, coma and death. Excessive administration of sodium chloride solution 0.9% can cause hypernatremia. Excessive intake of chloride into the body can lead to hyperchloremic acidosis. If a solution of sodium chloride 0.9% is used as a base solution for the dilution and transport of other drugs, symptoms and complaints with excessive administration are most often associated with the properties of the drugs added to the solution. In case of unintentional over-administration of the solution, treatment should be stopped and the patient’s condition assessed.

Treatment: symptomatic.

Storage conditions

Store at a temperature not exceeding 30 °C.

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiration date.

Manufacturer

Grotex LLC, Russia